These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25618774)

  • 41. Metabolic changes in bladder cancer.
    Woolbright BL; Ayres M; Taylor JA
    Urol Oncol; 2018 Jul; 36(7):327-337. PubMed ID: 29773495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic landscape of the tumor microenvironment at single cell resolution.
    Xiao Z; Dai Z; Locasale JW
    Nat Commun; 2019 Aug; 10(1):3763. PubMed ID: 31434891
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hope in translation.
    Nature; 2010 Sep; 467(7315):499. PubMed ID: 20881968
    [No Abstract]   [Full Text] [Related]  

  • 44. Detachment stress mediated bioenergetic switch of malignant melanoma cells into anti-Warburg phenotype.
    Uen W; Tseng T; Wu CP; Lee S
    Aging (Albany NY); 2022 Jul; 14(13):5511-5522. PubMed ID: 35802540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypoxia potentiates the capacity of melanoma cells to evade cisplatin and doxorubicin cytotoxicity via glycolytic shift.
    Zhuo M; Gorgun FM; Tyler DS; Englander EW
    FEBS Open Bio; 2020 May; 10(5):789-801. PubMed ID: 32134564
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Invasive phenotype induced by low extracellular pH requires mitochondria dependent metabolic flexibility.
    Shin SC; Thomas D; Radhakrishnan P; Hollingsworth MA
    Biochem Biophys Res Commun; 2020 Feb; ():. PubMed ID: 32081432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Running to Outcompete Metastasis.
    Zerhouni M; Piskounova E
    Cancer Res; 2022 Nov; 82(22):4124-4125. PubMed ID: 36377384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Connecting Metabolic Rewiring With Phenotype Switching in Melanoma.
    Falletta P; Goding CR; Vivas-García Y
    Front Cell Dev Biol; 2022; 10():930250. PubMed ID: 35912100
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A melanoma molecular disease model.
    Vidwans SJ; Flaherty KT; Fisher DE; Tenenbaum JM; Travers MD; Shrager J
    PLoS One; 2011 Mar; 6(3):e18257. PubMed ID: 21479172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Going forward together: cooperative invasion in melanoma.
    Wojciechowska S; Patton EE
    Pigment Cell Melanoma Res; 2015 Jan; 28(1):6-7. PubMed ID: 25308321
    [No Abstract]   [Full Text] [Related]  

  • 51. Bioenergetic cellular index: a clinical biomarker to identify metabolic adaption in melanoma?
    Armstrong J
    Br J Dermatol; 2019 Jul; 181(1):15-16. PubMed ID: 31259409
    [No Abstract]   [Full Text] [Related]  

  • 52. Fishing for melanoma drivers.
    Hurlstone A
    Pigment Cell Melanoma Res; 2014 Mar; 27(2):155-6. PubMed ID: 24406049
    [No Abstract]   [Full Text] [Related]  

  • 53. The melanocyte lineage in development and disease.
    Mort RL; Jackson IJ; Patton EE
    Development; 2015 Feb; 142(4):620-32. PubMed ID: 25670789
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BRAF inhibitor resistance mediated by the AKT pathway in an oncogenic BRAF mouse melanoma model.
    Perna D; Karreth FA; Rust AG; Perez-Mancera PA; Rashid M; Iorio F; Alifrangis C; Arends MJ; Bosenberg MW; Bollag G; Tuveson DA; Adams DJ
    Proc Natl Acad Sci U S A; 2015 Feb; 112(6):E536-45. PubMed ID: 25624498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mitochondrial reactive oxygen species and cancer.
    Sullivan LB; Chandel NS
    Cancer Metab; 2014; 2():17. PubMed ID: 25671107
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolic rewiring in melanoma.
    Ratnikov BI; Scott DA; Osterman AL; Smith JW; Ronai ZA
    Oncogene; 2017 Jan; 36(2):147-157. PubMed ID: 27270434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA.
    Serguienko A; Grad I; Wennerstrøm AB; Meza-Zepeda LA; Thiede B; Stratford EW; Myklebost O; Munthe E
    Oncotarget; 2015 Feb; 6(4):2451-65. PubMed ID: 25669981
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitochondria as biosynthetic factories for cancer proliferation.
    Ahn CS; Metallo CM
    Cancer Metab; 2015; 3(1):1. PubMed ID: 25621173
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The genetic basis of new treatment modalities in melanoma.
    Kunz M
    Curr Drug Targets; 2015; 16(3):233-48. PubMed ID: 25654738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies.
    Spagnolo F; Ghiorzo P; Orgiano L; Pastorino L; Picasso V; Tornari E; Ottaviano V; Queirolo P
    Onco Targets Ther; 2015; 8():157-68. PubMed ID: 25653539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.